Minetta C. Liu

Oncology

5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 216 publications

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Association between exposure to bedroom light-at-night and depressive symptoms in children and adolescents

Association between exposure to bedroom light-at-night and depressive symptoms in children and adolescents

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: July 27, 2026

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.

Journal: JAMA oncology

Published: July 03, 2026

Associations between early changes in circulating tumor DNA (ctDNA) and outcomes across randomized trials: Insights from the ctMoniTR project.

Associations between early changes in circulating tumor DNA (ctDNA) and outcomes across randomized trials: Insights from the ctMoniTR project.

Journal: The journal of liquid biopsy

Published: June 15, 2026

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

Journal: ESMO gastrointestinal oncology

Published: May 28, 2026

CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.

CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 27, 2026

Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

Journal: Science translational medicine

Published: April 22, 2026

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.

Journal: Annals of surgery

Published: April 09, 2026

Cancer incidence and mortality across diverse geographical regions in China, 2024

Cancer incidence and mortality across diverse geographical regions in China, 2024

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: March 24, 2026

Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab.

Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab.

Journal: European urology oncology

Published: March 20, 2026

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Journal: JCO precision oncology

Published: March 02, 2026

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial.

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial.

Journal: Research square

Published: February 23, 2026

Showing 1-12 of 216

Last Updated: 09/26/2026